INTRODUCTION
Most couples seeking infertility treatment are subfertile and IUI is the first effective treatment chosen for suitably selected patients. IUI is the mode of treatment in infertility due to cervical factor, ovulatory dysfunction, endometriosis, immunological causes, male factor and unexplained infertility. 1, 2, 3 IUI is less invasive, cost effective and an intermediate step before the application of sophisticated assisted reproductive technologies (ART) such as invitro fertilization (IVF) with or without intracytoplasmic sperm injection (ICSI). 4 The success rate of IUI depends on several factors with pregnancy rates ranging from as low as 5% to as high as 70% per patient; however, a 10-20% clinical pregnancy per cycle is an acceptable range for all aetiologies. IUI may be performed in natural cycle as well as in combination with controlled ovarian hyperstimulation (COH). When used in conjunction with COH in unexplained infertility, cumulative pregnancy rates may approach those of ART. 5, 6 In this retrospective study we have attempted to identify prognostic factors for the chance of pregnancy. These data would help clinicians in planning infertility treatment and predicting the success rate of IUI in individual couples. All subjects were couples for therapeutic IUI for the treatment of unexplained infertility, mild sperm dysfunction and anovulation. The study couples with at least one year of infertility underwent a basic infertility evaluation consisting of precise history taking, detailed clinical examination, laboratory test (prolactin and thyroid hormone concentration), tubal patency tests with hysterosalpingography (HSG)/ laparoscopy and uterine cavity evaluation with HSG/ hysteroscopy. Among women with infertility of less than two years or intrauterine pregnancy in the immediate past and no history suggestive of tuboperitoneal disease, tubal and uterine cavity evaluation was not always carried out before the first IUI treatment. However, tubal patency test was done if pregnancy did not occur after 2-3 cycles of IUI. The couples with tubal and severe male factor infertility (progressive motile sperm count <1million/ml) and endocrine diseases were excluded from the study.
METHODS

This
Male factor infertility was defined as: (i) a sperm count of <20 million/ml; (ii) normal morphology <30% or (iii) progressive motility (grade A+B) <40% before sperm preparation modifying World Health Organisation guidelines (1989) The two methods of ovarian stimulation used in our study were: (i) administration of 50-100 mg clomiphene citrate (CC) from day 3 to 7 of the cycle; (ii) administration of CC and human menopausal gonadotropin (HMG+CC), CC was prescribed from day 3 to 7 and intramuscular injection of 75mg of HMG on day 5,7 and 9.
Ovarian and endometrial responses were monitored using transvaginal sonography on day 9 to 13. All subjects were given intramuscular injection of 5000 IU human chorionic gonadotrophin (HCG) when atleast one dominant follicle was >17mm. IUI was performed 36 hours after administration of HCG using a simple IUI catheter under ultrasound guidance. IUI was repeated the next day if the follicle had not ruptured. A standard inseminate volume of one ml prepared using swim up method was used. The patients were advised to rest for 20 min following IUI. Micronised progesterone vaginal pessaries (400mg bd) were prescribed for luteal phase support for 14 days post IUI.
The descriptive variables recorded were couple's age, duration of infertility, number of follicles, size of follicles, endometrial thickness, single/double IUI, number of IUI cycles, sperm concentration and sperm motility. The statistical analysis was done using SPSS statistical software (version 12). A logistic regression analysis method was used to identify significant variable that contribute to the success of IUI and to predict the probability of pregnancy for each cycle. P value <0.05 was considered to be of statistical significance.
RESULTS
A total of 264 IUI cycles were analysed. The overall pregnancy rate per cycle and per couple was 3.8% (10/264) and 17.25% (10/58) respectively. IUI result according to female characteristics and sperm parameters (after preparation) are given in Table 1 . The average female and male age was 26.4 + 5.35 years and 33.6 ± 4.9 years respectively in the participants with positive IUI result. Both were not statistically significant. Duration of infertility, type of infertility, endometrial thickness, number of follicles, size of follicles, sperm count, sperm motility and single/double IUI did not significantly affect the outcome of IUI. However, logistic regression analysis showed significant relationship between pregnancy occurrence and number of follicles and number of IUI cycles ( Table 2 ). 
DISCUSSION
In this study we attempted to identify prognostic factors associated with success in clomiphene citrate / CC+HMG/ IUI treatment. We carried out logistic regression analysis of 264 IUI cycles and identified two significant variables: these are number of pre-ovulatory follicles and number of treatment cycles.
In our study the overall pregnancy rate for all cycles was 17.25% which is similar to the other studies. 7, 8 The
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International Journal of Reproduction, Contraception, Obstetrics and Gynecology Volume 2 · Issue 3 Page 313 fecundity rates for patients undergoing ovarian stimulation with IUI have varied from 7 to 29%. [9] [10] [11] [12] In Houmard et al 9 study, the lower clinical pregnancy was attributed to higher maternal age and lower ovulatory disorder cases .These differences between other studies and ours are probably due to different causes of infertility, type of treatment and younger women seeking infertility treatment in our country. In this study, the average female and male age did not show any influence on IUI results. The advancing maternal age decreases female fecundity 13 and this is due to reduced uterine receptivity 14 and/ or decreased oocyte quality. However, the prognostic value of woman's age was not significant in studies undertaken by Brzechffa et al 15 and Tomlinson et al 16 which was similar to our study.
We did not find significant influence on pregnancy rate with an increasing duration of infertility as shown by other studies. 17, 18 However, various studies have shown duration of infertility as a significant prognostic factor. 16, 19 In our study, the number of follicles was a prognostic predictor of IUI outcome, which is similar to that found in earlier studies. 20, 21 The positive relationship between follicle count and IUI success could be due to increased chances of fertilization and implantation. Sperm count and progressive motility after preparation were not indicator of IUI success. This is due to sperm screening prior to IUI and exclusion of couples with a progressively motile sperm count of <1 million/ml.
In the present study number of treatment cycles was a good prognostic indicator and the pregnancy chances were highest in first two treatment cycles. In the literature, the decreasing pregnancy rates with an increased number of treatment cycles have also shown similar to our results. 8, 22 The number of treatment cycles should be limited in women >40 years and severe male factor infertility.
Insemination frequency (single/double IUI) did not show significant impact on IUI outcome. Several studies 23, 24 showed increased probability with double IUI compared to single IUI.
The cost effectiveness of the treatment is important in making decision regarding different treatment options. In our hospital the cost of IVF treatment is over five fold higher compared to CC/CC+HMG/IUI. In addition longer time off work and higher multiple pregnancy rates following IVF treatment further favours the costeffectiveness of IUI treatment.
The principal weakness of this study, in addition to the fact that it is a retrospective study and not randomized, is the small number of subjects.
CONCLUSION
Clomiphene citrate/ CC+HMG/ IUI is a useful and cost effective treatment option for infertility. We find that two variables have significant prognostic value with regard to IUI success: number of follicles and number of treatment cycles. Careful patient selection criteria along with successful ovarian stimulation enhances the treatment outcome. This information will help us in counseling infertile couple and make it possible to carry out more precise patient selection, preventing any wasteful and unnecessary treatment and increase the cost-effectiveness of IUI therapy.
